Zentalis Pharmaceuticals ZNTL
NASDAQ ZNTL
$2.36 -0.03 (-1.26%)
At close: Oct 21, 2026 · 4:00 PM EDT

Zentalis Pharmaceuticals (ZNTL) Net Margin (2024)

Updated

Zentalis Pharmaceuticals' Net Margin was -176.71% in Q4 2024.

Analysis

Zentalis Pharmaceuticals (ZNTL) Net Margin (2024) Analysis & Trends

For FY2024, Net Margin at Zentalis Pharmaceuticals came in at -245.96%.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 30.88%
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 21.86%
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 21.27%
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -8.04%
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 22.65%
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 16.30%
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 23.62%
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -134.51%
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -1.65%
10 Zentalis Pharmaceuticals 167.62 Mn -742.93 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 -176.71%
Mar 31, 2024 24.82%
API Access

Zentalis Pharmaceuticals Net Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-margin&ticker=ZNTL&period=max&api_key=YOUR_API_KEY